pd 98059 has been researched along with EBV Infections in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S | 1 |
| Li, H | 1 |
| Chen, L | 1 |
| Yang, L | 1 |
| Li, L | 1 |
| Tao, Y | 1 |
| Li, W | 1 |
| Li, Z | 1 |
| Liu, H | 1 |
| Tang, M | 1 |
| Bode, AM | 1 |
| Dong, Z | 1 |
| Cao, Y | 1 |
1 other study available for pd 98059 and EBV Infections
| Article | Year |
|---|---|
(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.
Topics: Antiviral Agents; Catechin; Cell Line, Tumor; Cell Survival; Chromones; DNA, Viral; Enzyme Activatio | 2013 |